Tanabe Pharma Corporation
Records under this name other than the patents Tanabe Pharma Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.
Showing 1 to 3 of 3 · Back to Tanabe Pharma Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,511,020 | Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides Term ended Term ended Sep 23, 2024 · From the USPTO record | Term ended | Term ended Sep 23, 2024 | From the USPTO record |
| US 7,511,021 | Substituted indazole-O-glucosides Term ended Term ended Sep 15, 2024 · From the USPTO record | Term ended | Term ended Sep 15, 2024 | From the USPTO record |
| US 7,482,330 | Substituted fused heterocyclic C-glycosides Term ended Term ended Sep 4, 2024 · From the USPTO record | Term ended | Term ended Sep 4, 2024 | From the USPTO record |